Is clinical stage T2c prostate cancer an intermediate- or high-risk disease?

Zachary Klaassen, Abhay A. Singh, Lauren E. Howard, Zhaoyong Feng, Bruce Trock, Martha K. Terris, William J. Aronson, Matthew R. Cooperberg, Christopher L. Amling, Christopher J. Kane, Alan Partin, Misop Han, Stephen J. Freedland

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Is clinical stage T2c prostate cancer an intermediate- or high-risk disease?'. Together they form a unique fingerprint.

Medicine & Life Sciences